Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Pilot Trial to Address the Feasibility and Safety of Treatment With Oral Zinc in GNAO1 Associated Disorders

NCT06412653 is registered in ClinicalTrials.gov with Children's University Hospital Cologne, Germany as lead sponsor.

NCT NCT06412653
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06412653 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Pilot Trial to Address the Feasibility and Safety of Treatment With Oral Zinc in GNAO1 Associated Disorders
Lead sponsor
Children's University Hospital Cologne, Germany
Phase
Phase 2
Overall status
Completed
Start date
August 2, 2024
Completion date
August 4, 2025
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

choreoathetosis, development delay, developmental and epileptic encephalopathy 17, dystonia, epilepsy, gnao1, neurodevelopmental disorder with involuntary movements